Financials

  • Market Capitalization 1.78 B
  • Employee 130
  • Founded 2019
  • CEO N/A
  • Website www.septerna.com
  • Headquarter Delaware, United States
  • FIGI BBG014WY1V28
  • Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-63.19
売上高対価格比率
15.2

Related tickers

#名前価格24時間%7日%1か月%1年%時価総額過去7日
2069
RXRX
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.40 USD+1.80%+3.98%+12.21%-25.93%1.82 B USD
2084
NTLA
Intellia Therapeutics, Inc. - Common Stock
12.73 USD-1.09%-0.55%+20.21%-7.22%1.78 B USD
2096
FTRE
Fortrea Holdings Inc. - Common Stock
18.37 USD-2.34%+0.22%-4.52%+90.56%1.75 B USD
2108
SNDX
Syndax Pharmaceuticals, Inc. - Common Stock
19.29 USD-1.28%-2.23%+1.47%+16.91%1.72 B USD